Hwail Pharm Co Ltd
KOSDAQ:061250
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
H
|
Hwail Pharm Co Ltd
KOSDAQ:061250
|
KR |
|
G
|
Global Top E-Commerce Co Ltd
SZSE:002640
|
CN |
|
Z
|
Zhongzheng International Co Ltd
HKEX:943
|
HK |
|
H
|
HDC Hyundai Engineering Plastics Co Ltd
KRX:089470
|
KR |
|
C
|
Creverse Inc
KOSDAQ:096240
|
KR |
|
VVC Exploration Corp
XTSX:VVC
|
CA |
|
A
|
Afi Properties Ltd
TASE:AFPR
|
IL |
|
S
|
Sambo Industrial Co Ltd
KOSDAQ:009620
|
KR |
|
Insigma Technology Co Ltd
SSE:600797
|
CN |
|
A
|
Artini Holdings Ltd
HKEX:789
|
HK |
|
Resurs Holding AB (publ)
STO:RESURS
|
SE |
|
P
|
Pomi Frutas SA - em Recuperacao Judicial
BOVESPA:FRTA3
|
BR |
|
D
|
Duncan Engineering Ltd
BSE:504908
|
IN |
|
WuXi Xinje Electric Co Ltd
SSE:603416
|
CN |
|
China Citic Bank Corp Ltd
OTC:CHBJF
|
CN |
|
P
|
PNC Process Systems Co Ltd
SSE:603690
|
CN |
|
M
|
Maverick Energy Group Ltd
OTC:MKGP
|
US |
|
Dynavox Group AB
STO:DYVOX
|
SE |
|
C
|
Central African Gold Inc
OTC:NDENF
|
CA |
|
A
|
Ayvens SA
OTC:ALLDF
|
FR |
|
Shihlin Electric & Engineering Corp
TWSE:1503
|
TW |
|
Grifols SA
OTC:GIFOF
|
ES |
Hwail Pharm Co Ltd
HWAIL PHARMACEUTICAL Co., Ltd. engages in the manufacture and sale of pharmaceutical products. The company is headquartered in Hwaseong, Gyeonggi-Do and currently employs 149 full-time employees. The company went IPO on 2002-04-18. The firm produces aceclofenac, lornoxicam, triflusal, dicloalphenazone, gallamine triethyl iodide, acemetacin, levosulpiride, alibendol, erdostein, talniflumate, topiramate, phloroglucin, oxatomide and others used as expectorants, cough remedies, antispasmodics, analgesics, anti-inflammatories and others under the brand name EDST, TRPR, LVSP, ACCL and others. The company also provides finished formulations, including injection products such as ceftazidime, cefoperazone, cefotaxime, cefaclor, cefatrizine, cefroxadine and others. The firm distributes its products within domestic market and to overseas markets.
HWAIL PHARMACEUTICAL Co., Ltd. engages in the manufacture and sale of pharmaceutical products. The company is headquartered in Hwaseong, Gyeonggi-Do and currently employs 149 full-time employees. The company went IPO on 2002-04-18. The firm produces aceclofenac, lornoxicam, triflusal, dicloalphenazone, gallamine triethyl iodide, acemetacin, levosulpiride, alibendol, erdostein, talniflumate, topiramate, phloroglucin, oxatomide and others used as expectorants, cough remedies, antispasmodics, analgesics, anti-inflammatories and others under the brand name EDST, TRPR, LVSP, ACCL and others. The company also provides finished formulations, including injection products such as ceftazidime, cefoperazone, cefotaxime, cefaclor, cefatrizine, cefroxadine and others. The firm distributes its products within domestic market and to overseas markets.
